Market growth is shifting toward emerging markets in Asia, Latin America and elsewhere, where pharmaceutical sales are forecast to expand at double digit rates
With regulatory requirements in emerging markets changing and differing significantly to European/US requirements, it is essential to stay on top of the requirements and remain compliant.
Meanwhile, updates on global eSubmissions, plans for implementing eCTD within National Procedures and SPOR now taking hold for those in regulatory information management, there are numerous challenges ahead for publishing and operations professionals as they plan their regulatory strategy. Moreover, those tasked with filing variations will have the chance to hear updates from around the world and help them to create a global strategy.
Taking place just days after Brexit, book your place to ensure you’re prepared for how this will impact the pharmaceutical industry and your regulatory strategy.
